Olympus Enters Into Distribution Deal for Disposable Endoscope Valves

by KJ McElrath | Oct 24, 2017 | Pharmaceutical Industry |

Olympus, the manufacturer of endoscopes that have been implicated in serious infections and at...

“Magic” Psilocybin Mushrooms Offer Hope to Patients Suffering From Depression – Yet, They Remain Illegal

by KJ McElrath | Oct 21, 2017 | Pharmaceutical Industry |

The dangers of antidepressant drugs have become quite apparent over the past several years....

Anti-Psychotic Medications: There Are Healthier, Less Risky Alternatives

by KJ McElrath | Oct 7, 2017 | Pharmaceutical Industry |

It is no secret that Americans are the most over-medicated people on the planet – particularly...

FDA Announces Plans to Rein in Drug Prices – Will They Work?

by KJ McElrath | Oct 3, 2017 | Pharmaceutical Industry |

The subject of price gouging by Big Pharma has become such a hot-button issue that even the...

The FDA’s “Orphan Drug” Program is Turning into a Cash Cow For Big Pharma

by KJ McElrath | Sep 15, 2017 | Pharmaceutical Industry |

The intentions behind the Orphan Drug Act of 1983 may have been good ones, but in recent years, it...

Guaranteed, Single-Payer Health Care: It’s Not Just Good for People, It’s Good for Business

by KJ McElrath | Aug 26, 2017 | Pharmaceutical Industry |

Imagine you are running your own company – or perhaps you already do. Would it help if you were...